HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Protein intake in infancy and carotid intima media thickness at 5 years--a secondary analysis from a randomized trial.

AbstractBACKGROUND:
Nutrition in childhood has an influence on the cardiovascular function later on in life. European Childhood Obesity Project is a multicenter, randomized clinical intervention trial examining the effect of early protein intake on later health outcomes, particularly adiposity and related disorders. The aim of the study was to examine the effect of nutritional intervention--different protein intake in infancy on carotid intima-media thickness (cIMT) at 5 years. The association of cardiovascular risk factors with cIMT was also assessed.
METHODS:
Healthy term formula-fed infants in five European countries were enrolled either to the higher (HP) or to the lower (LP) protein group. Observational group consisted of breastfed infants. Plasma insulin, glucose, lipid profile, IGF-1, apolipoprotein A1 and B were measured as well as anthropometric parameters of parents and a child, blood pressure and physical activity.
RESULTS:
No difference in cIMT between HP and LP group was observed. Insulin, HOMA-IR index and total IGF-1 were positively associated with cIMT but after adjustment for confounders only an inverse association between ApoA1 and positive between ApoB/ApoA1 and cIMT were significant.
CONCLUSION:
High versus low protein intake in infancy does not influence cIMT at 5 years. cIMT in healthy children at 5 years is associated with their apolipoprotein profile.
AuthorsDariusz Gruszfeld, Martina Weber, Monika Nowakowska-Rysz, Roman Janas, Rainer Kozlik-Feldmann, Annick Xhonneux, Clotilde Carlier, Enrica Riva, Elvira Verduci, Ricardo Closa-Monasterolo, Joaquin Escribano, Anna Dobrzanska, Berthold Koletzko, European Childhood Obesity Study Group
JournalAnnals of nutrition & metabolism (Ann Nutr Metab) Vol. 66 Issue 1 Pg. 51-9 ( 2015) ISSN: 1421-9697 [Electronic] Switzerland
PMID25572773 (Publication Type: Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
Copyright© 2015 S. Karger AG, Basel.
Chemical References
  • APOB protein, human
  • Apolipoprotein A-I
  • Apolipoprotein B-100
  • Blood Glucose
  • Dietary Proteins
  • Insulin
  • Lipids
  • Insulin-Like Growth Factor I
Topics
  • Apolipoprotein A-I (blood)
  • Apolipoprotein B-100 (blood)
  • Blood Glucose
  • Blood Pressure
  • Body Mass Index
  • Breast Feeding
  • Cardiovascular Diseases (pathology, prevention & control)
  • Carotid Intima-Media Thickness (statistics & numerical data)
  • Child, Preschool
  • Dietary Proteins (administration & dosage)
  • Europe
  • Female
  • Follow-Up Studies
  • Humans
  • Infant
  • Infant Formula (administration & dosage)
  • Infant Nutritional Physiological Phenomena
  • Infant, Newborn
  • Insulin (blood)
  • Insulin-Like Growth Factor I (analysis)
  • Lipids (blood)
  • Male
  • Motor Activity
  • Risk Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: